January, 2006
For the five preventive conditions examined (including two types of cancer screening), it was determined that the provision of increased access to NEMT for the transportation-disadvantaged population is cost-effective for all five, because projected improvements in life expectancy and quality of life are large enough to justify the net cost increases.
January, 2006
For the five preventive conditions examined, the results show a net cost saving, whereas for the other four, improvements in life expectancy or quality of life are sufficient to justify the added expense.
January, 2006
Adding relatively small transportation costs to an otherwise disease-specific, cost-effective environment does not make improved access to care non-cost-effective. For example, a congestive heart failure monitoring program that is already evaluated as highly cost-effective will not transition to cost-ineffective because of the addition of only incremental transportation costs.
January, 2006
On the basis of their demographic, socioeconomic, and health characteristics, members of the target population (to receive NEMT) also appear to be more likely than others to live in less healthy environments, exacerbating their need for health care visits.
January, 2006
Those who fall into the target population of 3.6 million who miss or delay care due to lack of transportation possess distinct characteristics that separate them from the rest of the U.S. population, and these are explained in detail in the earlier paper (1) and a TCRP report stemming from this project (2). In short, […]